Predict your next investment

HEALTHCARE | Disease Diagnosis
pacificedgedx.com

See what CB Insights has to offer

Stage

PIPE | IPO

Market Cap

0.86B

About Pacific Edge

Pacific Edge (NZX:PEB) is a cancer diagnostics company that offers a genetic biomarker-based suite of bladder cancer diagnostic tools. The company has offices in Hershey, USA, with its head office in Dunedin, New Zealand.

Pacific Edge Headquarter Location

87 St David St PO Box 56

Dunedin, 9016,

New Zealand

+64 3 479-5800

Latest Pacific Edge News

Blis enters into partnership with Probi

Jul 7, 2021

You are not permitted to download, save or email this image. Visit image gallery to purchase the image. Blis Technologies has entered into a long-term strategic partnership with a Swedish global probiotics company, which will take a 13% shareholding in the Dunedin company. A licence and supply agreement has been established, under which Blis has granted Probi rights to manufacture and sell Blis K12 and Blis M18 probiotics. A cash issue of $9.18 million of new shares to Probi would result in a 13% shareholding and provide the company with capital to support Blis’ revenue growth initiatives, a note to the NZX said yesterday. Since its establishment at Sweden’s Lund University in 1991, Probi — which is listed on Nasdaq Stockholm — has expanded operations to more than 40 markets and holds more than 500 patents globally. It focused on researching, manufacturing and delivering probiotics for supplements and functional food. The partnership was an ‘‘exciting opportunity’’ for the company and a significant endorsement of Blis, chairman Tony Offen said. ‘‘Probi provides extensive international industry experience and relationships which will drive collaboration opportunities and revenue growth,’’ Mr Offen said. Probi chief executive Tom Ronnlund said it was a compelling business partnership as Blis was an innovative, science-led company with leading market share in probiotic oral health. ‘‘Through this partnership, we will broaden our portfolio and strengthen our position as leaders in the use of clinically documented bacterial strains. ‘‘Beyond immediate commercial opportunities, the partnership also included research collaboration. Blis previously announced revenue of $10.6 million, ebitda of $1 million, and net profit of $0.6 million for the year to March 31, its third consecutive profitable year. At that time, the company said the delivery of meaningful longer-term growth would require ongoing investment upfront. It was its expectation that, in the longer-term, finished products would comprise the majority of its sales revenue. Investment in innovation and science would continue and the assessment of new and emerging market opportunities would be actively sought to capitalise on the international reach those opportunities could deliver. Mr Ronnlund would join the Blis board after its annual meeting of shareholders which will be held on Wednesday, July 21, at the Dunedin Public Art Gallery. Another Dunedin biotech company’s domestic business continues to grow as the Northland District Health Board adopts the full suite of Pacific Edge’s Cxbladder tests. Yesterday, Pacific Edge announced it had reached commercial agreement with the Northland DHB and Northland’s primary health entity Mahitahi Hauora for the use of Cxbladder products. Northland DHB serves a population of more than 190,000, of which about one-third are Maori, and with a higher than average number of people aged 50 or older. Under the new programme, patients with blood in their urine will be referred by their primary care physician for the Cxbladder Triage test and will be able to provide a urine specimen at their local diagnostic laboratory, possibly avoiding the need to travel long distances to a urology clinic or hospital for investigation. A pilot scheme of Cxbladder testing in Northland showed more than half of patients being evaluated for haematuria (blood in their urine), or being followed up for bladder cancer, could have avoided an invasive cystoscopy procedure based on their Cxbladder test results, Pacific Edge vice-president commercial and franchise Brent Pownall said.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Pacific Edge

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pacific Edge is included in 1 Expert Collection, including Cancer.

C

Cancer

4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Pacific Edge Patents

Pacific Edge has filed 9 patents.

The 3 most popular patent topics include:

  • Oncology
  • Transcription factors
  • Genetics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/31/2016

6/23/2020

Oncology, Molecular biology, Transcription factors, Clusters of differentiation, Monoclonal antibodies

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

8/31/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/23/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Oncology, Molecular biology, Transcription factors, Clusters of differentiation, Monoclonal antibodies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Pacific Edge Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Pacific Edge Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.